TransPerfect Acquires Synterex to Enhance Medical Writing and AI Solutions

TransPerfect Expands Medical Writing Expertise with Synterex Acquisition

TransPerfect, recognized globally as a leader in language and AI service solutions, has taken a significant step in enhancing its capabilities in the biotech and pharmaceutical sectors with its recent acquisition of Synterex. This move, announced on October 1, 2026, underscores TransPerfect's commitment to integrating advanced AI technologies in the realm of medical writing and regulatory documentation.

What is Synterex?

Based in Dedham, Massachusetts, Synterex is a pioneering consulting firm, uniquely distinguished as a disability-owned and woman-owned business. It specializes in clinical and regulatory writing and has made a name for itself by delivering efficient development solutions tailored to the specialized needs of the biotechnology and pharmaceutical industries. The incorporation of their AgileWriter.ai® platform into TransPerfect's offerings promises to streamline content creation workflows while reducing the manual efforts traditionally associated with regulatory documentation.

The Impact of the Acquisition

This acquisition is set to establish a unified system for managing regulated content, spanning the entire process from document creation to final submission. By harnessing the combined expertise of Synterex and the existing framework of TransPerfect Life Sciences, this move will not only enhance service delivery but also minimize delays often associated with handoffs in document management. This seamless integration is critical for companies that must adhere to strict regulatory standards while aiming to leverage AI technologies to improve efficiency.

Jeanette Towles, the Founder and President of Synterex, expressed her enthusiasm about the merger, stating that from the initial discussions, it became clear that TransPerfect shares a mutual vision about the future of medical writing. She emphasized that Synterex was built on a foundation that values strong scientific expertise, innovative working methodologies, and responsible technological applications. This merger presents a remarkable opportunity to blend these philosophies with TransPerfect's expansive global resources and client partnerships.

Technology Meets Expertise

The synergy created by this acquisition also promises to elevate the quality and efficiency of regulatory writing processes. The AgileWriter platform, equipped with AI-assisted authoring capabilities, enables clients to maintain rigorous standards of governance and traceability. These features are crucial in the highly regulated environments of biotech and pharmaceuticals, where accuracy and compliance with legal standards are non-negotiable.

As Synterex integrates into TransPerfect Life Sciences, its team, led by Towles, will continue its operations and focus on advancing methodologies and technologies that enhance the clinical and regulatory writing landscape. This strategic move positions TransPerfect to not only expand its service offerings but also deepen its commitment to the biotech and pharmaceutical sectors, enhancing patient care through improved documentation processes.

Looking Ahead

The future of medical writing and regulatory documentation is poised for transformation. TransPerfect’s acquisition of Synterex is a proactive response to the growing demand for AI-driven solutions in clinical development processes. As regulations evolve and the healthcare landscape becomes increasingly complex, the combination of Synterex's innovative technologies with TransPerfect's robust network will enhance compliance and efficiency.

TransPerfect is positioned as a vanguard player in the medical writing industry—ready to address the challenges faced by organizations in navigating regulatory demands without compromising the quality of service. As both firms move forward, they aim to ensure that human judgment, client needs, and overall service quality remain at the forefront of their combined operations.

In conclusion, the collaboration between TransPerfect and Synterex represents a forward-thinking approach to medical writing and regulatory solutions in the life sciences sector. This partnership not only stands to benefit organizations but ultimately serves to elevate the standards of patient care globally.